Damian Tiberiu, Noel Spielhofer, Jakob Heimer, Alexander W Sauter, Cristina Popescu, Daniel Hausmann, Jason L Manser, Karim Eid, Rahel A Kubik-Huch, Irene A Burger
{"title":"[99m锝]锝-HDP 骨 SPECT/CT 定量:能否通过更稳健的归一化改进基于体重的标准化摄取值?","authors":"Damian Tiberiu, Noel Spielhofer, Jakob Heimer, Alexander W Sauter, Cristina Popescu, Daniel Hausmann, Jason L Manser, Karim Eid, Rahel A Kubik-Huch, Irene A Burger","doi":"10.1186/s13550-024-01167-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The introduction of quantitative SPECT/CT allows more objective assessments of tracer accumulation in SPECT. However standardized uptake values (SUV) still do not play a big role for orthopedic or oncologic questions. With a more reliable normalization, the use of quantitative measures might also be of use for a more objective assessment of lesions. We retrospectively included patients that received a quantitative [<sup>99m</sup>Tc]-HDP bone SPECT/CT scan of the lumbar spine for 4 body weight (BW) categories. Measurements of bone activity (kBq/cc) and bone density in Hounsfield Units (HU) in a standard volume of interest in the femur, the first and the fifth lumbar vertebra of all patients, without active disease within these regions was made. Correlations between tracer uptake and clinical parameters (BW, height, age, gender) were assessed with a multiple regression and based on the model coefficients, a correction formula was calculated and applied.</p><p><strong>Results: </strong>The strongest correlation between measured activity in L1 and patient parameters was found for BW (r= -0.64, p < 0.001), compared to height (r = -0.28, p = 0.002) and age (r = -0.34, p = 0.001). Furthermore, there was a weak positive correlation between tracer accumulation and bone density (r: 0.35, p < 0.001). Using standard normalization with BW there was a very weak positive correlation between SUV<sub>BW</sub> at L1 and BW with a slight overestimation in heavier subjects (r = 0.15, p = 0.09). The calculated correction based on the multiple regression of activity as dependent variable, and weight, age and bone density as significant predictors resulted in more robust uptake values with non-significant associations to BW, height, age or density. However, there was still a wide interindividual range of values for normalized bone activity.</p><p><strong>Conclusion: </strong>Using an age, bone density and weight-based normalization significantly decreased the interindividual variability of normal uptake on quantitative SPECT/CT compared to the regularly used BW adjusted SUV<sub>BW</sub>. However, a generalized normalization is difficult in the presence of strong patient effects, not attributable to the measured clinical variables.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"14 1","pages":"111"},"PeriodicalIF":3.1000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576713/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quantification of [<sup>99m</sup>Tc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?\",\"authors\":\"Damian Tiberiu, Noel Spielhofer, Jakob Heimer, Alexander W Sauter, Cristina Popescu, Daniel Hausmann, Jason L Manser, Karim Eid, Rahel A Kubik-Huch, Irene A Burger\",\"doi\":\"10.1186/s13550-024-01167-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The introduction of quantitative SPECT/CT allows more objective assessments of tracer accumulation in SPECT. However standardized uptake values (SUV) still do not play a big role for orthopedic or oncologic questions. With a more reliable normalization, the use of quantitative measures might also be of use for a more objective assessment of lesions. We retrospectively included patients that received a quantitative [<sup>99m</sup>Tc]-HDP bone SPECT/CT scan of the lumbar spine for 4 body weight (BW) categories. Measurements of bone activity (kBq/cc) and bone density in Hounsfield Units (HU) in a standard volume of interest in the femur, the first and the fifth lumbar vertebra of all patients, without active disease within these regions was made. Correlations between tracer uptake and clinical parameters (BW, height, age, gender) were assessed with a multiple regression and based on the model coefficients, a correction formula was calculated and applied.</p><p><strong>Results: </strong>The strongest correlation between measured activity in L1 and patient parameters was found for BW (r= -0.64, p < 0.001), compared to height (r = -0.28, p = 0.002) and age (r = -0.34, p = 0.001). Furthermore, there was a weak positive correlation between tracer accumulation and bone density (r: 0.35, p < 0.001). Using standard normalization with BW there was a very weak positive correlation between SUV<sub>BW</sub> at L1 and BW with a slight overestimation in heavier subjects (r = 0.15, p = 0.09). The calculated correction based on the multiple regression of activity as dependent variable, and weight, age and bone density as significant predictors resulted in more robust uptake values with non-significant associations to BW, height, age or density. However, there was still a wide interindividual range of values for normalized bone activity.</p><p><strong>Conclusion: </strong>Using an age, bone density and weight-based normalization significantly decreased the interindividual variability of normal uptake on quantitative SPECT/CT compared to the regularly used BW adjusted SUV<sub>BW</sub>. However, a generalized normalization is difficult in the presence of strong patient effects, not attributable to the measured clinical variables.</p>\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":\"14 1\",\"pages\":\"111\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576713/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-024-01167-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-024-01167-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?
Background: The introduction of quantitative SPECT/CT allows more objective assessments of tracer accumulation in SPECT. However standardized uptake values (SUV) still do not play a big role for orthopedic or oncologic questions. With a more reliable normalization, the use of quantitative measures might also be of use for a more objective assessment of lesions. We retrospectively included patients that received a quantitative [99mTc]-HDP bone SPECT/CT scan of the lumbar spine for 4 body weight (BW) categories. Measurements of bone activity (kBq/cc) and bone density in Hounsfield Units (HU) in a standard volume of interest in the femur, the first and the fifth lumbar vertebra of all patients, without active disease within these regions was made. Correlations between tracer uptake and clinical parameters (BW, height, age, gender) were assessed with a multiple regression and based on the model coefficients, a correction formula was calculated and applied.
Results: The strongest correlation between measured activity in L1 and patient parameters was found for BW (r= -0.64, p < 0.001), compared to height (r = -0.28, p = 0.002) and age (r = -0.34, p = 0.001). Furthermore, there was a weak positive correlation between tracer accumulation and bone density (r: 0.35, p < 0.001). Using standard normalization with BW there was a very weak positive correlation between SUVBW at L1 and BW with a slight overestimation in heavier subjects (r = 0.15, p = 0.09). The calculated correction based on the multiple regression of activity as dependent variable, and weight, age and bone density as significant predictors resulted in more robust uptake values with non-significant associations to BW, height, age or density. However, there was still a wide interindividual range of values for normalized bone activity.
Conclusion: Using an age, bone density and weight-based normalization significantly decreased the interindividual variability of normal uptake on quantitative SPECT/CT compared to the regularly used BW adjusted SUVBW. However, a generalized normalization is difficult in the presence of strong patient effects, not attributable to the measured clinical variables.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.